AKT inhibitor AZD5363 suppresses stemness and promotes anti-cancer activity of 3,3′-diindolylmethane in human breast cancer cells
- 1 October 2021
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 429, 115700
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81372837)
This publication has 24 references indexed in Scilit:
- PD‐L1 promotes OCT4 and Nanog expression in breast cancer stem cells by sustaining PI3K/AKT pathway activationInternational Journal of Cancer, 2017
- Toward deterministic and semiautomated SPADE analysisCytometry Part A, 2017
- Cellular and Molecular Mechanisms of 3,3′-Diindolylmethane in Gastrointestinal CancerInternational Journal of Molecular Sciences, 2016
- Visualization and cellular hierarchy inference of single-cell data using SPADENature Protocols, 2016
- Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studiesNutrition Reviews, 2016
- Imaging Immunosenescence2015
- Extracting a cellular hierarchy from high-dimensional cytometry data with SPADENature Biotechnology, 2011
- Regulation of FOXO3a/β-Catenin/GSK-3β Signaling by 3,3′-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Prostate Cancer CellsJournal of Biological Chemistry, 2007
- 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expressionCarcinogenesis, 2002
- Bcl-2 family-mediated apoptotic effects of 3,3′-diindolylmethane (DIM) in human breast cancer cellsBiochemical Pharmacology, 2002